Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/HUMANIGEN-INC-25805137/news/Humanigen-Inc-Erhalt-vorlaufige-Topline-Daten-aus-NIH-NIAID-Studie-zu-Lenzilumab-in-ACTIV-5-BET-40971510/?utm_source=whatsapp&utm_medium=social&utm_campaign=share